Bimatoprost
Product Description
C-squared PHARMA Limited
-
IE
-
2015On CPHI since
-
25 - 49Employees
Company types
Categories
Specifications
C-squared PHARMA Limited
-
IE
-
2015On CPHI since
-
25 - 49Employees
Company types
More Products from C-squared PHARMA Limited (12)
-
Product Atropine Sulfate
Filings: US-DMF, CEP, C-DMF*, K-DMF, T-DMF, MX, CADIFA*
*under submission/approval
C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Atropine Sulfate.
Atropin... -
Product Brimonidine Tartrate
Filings: US-DMF, CEP, C-DMF*, K-DMF, ASMF
*under submission/approval
C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Brimonidine Tartrate. As 0.2% ophthalmic solut... -
Product Cyclopentolate Hydrochloride
Filings: US-DMF, CEP, C-DMF
*under submission/approval
C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Cyclopentolate Hydrochloride.
It is used to cause my... -
Product Digoxin
Filings: US-DMF, CEP, C-DMF, J-DMF, K-DMF
*Under submission/approval
C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Digoxin.
C2 PHARMA is the only API manu... -
Product Digoxin Micronized
Filings: US-DMF, CEP, C-DMF, J-DMF, K-DMF, CADIFA*
*under submission/approval
C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Digoxin.
C2 PHARMA is the ... -
Product Homatropine Hydrobromide
Filings: US-DMF, CEP*
*under submission/approval
C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Homatropine Hydrobromide.
Homatropine Hydrobromide... -
Product Homatropine Methylbromide
Filings: US-DMF, CEP, T-DMF, CADIFA*
*under submission/approval
C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Homatropine Methylbromide.
Homatropine M... -
Product Latanoprost
Filings: US-DMF, CEP*, C-DMF, K-DMF, T-DMF
*under submission/approval
C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural which includes Latanoprost. It is used as a 0.005% ophthalmic solution for the... -
Product Pilocarpine Hydrochloride
Filings: US-DMF, CEP, C-DMF*, K-DMF, T-DMF, I-DMF*
*under submission/approval
C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Pilocarpine Hydrochloride.
Pilocarpine ... -
Product Naphazoline Hydrochloride
Filings: US-DMF*, CEP*, CADIFA*
*under submission/approval
C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Naphazoline Hydrochloride.
It is... -
Product Pilocarpine Nitrate
Filings: CEP, C-DMF, I-DMF*
*under submission/approval
C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Pilocarpine Nitrate.
Pilocarpine Nitrate is used topically ... -
Product Tropicamide
Filings: US-DMF, CEP, J-DMF*, C-DMF*, J-DMF*
*under submission/approval
C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Tropicamide.
As a 0.5% and 1% t...
C-squared PHARMA Limited resources (2)
-
News C2 PHARMA Expands Ophthalmic API Portfolio with Naphazoline Hydrochloride Launch
C2 PHARMA, a global provider of ophthalmic and niche active pharmaceutical ingredients (APIs), has launched its latest API, Naphazoline Hydrochloride. The validation campaign for Naphazoline HCL was completed in June 2024. A Certificate of Suitability (CEP) is under approval while the US-Drug Master File (US-DMF) is planned for submission by November 2024 and the API dossier for Brazil (DIFA) in December 2024. -
Brochure Ophthlamic Buyers Guide x PharmaSource
As the global leader in Ophthalmic APIs, C2 PHARMA was asked to participate in Pharmasource’s buyer guide focused on Ophthalmics.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance